Product Images Teriflunomide

This appears to be a table showing the number of participants at risk and disability progression sustained for 12 weeks across different treatment groups including a placebo group and groups treated with Teriflunomide Tablets of different doses (7 mg and 14 mg). There are also some percentages noted in the table.*

This appears to be a table displaying data related to disability progression and medication dosage for a 12-week period. The medication being studied is Terfunomide Tablets with dosages of 7mg and 14mg. The table shows the percentage of disability progression sustained for each week, as well as the number of participants at risk for each week.*

Teriflunomide Tablets containing 14mg each, with NDC code 0378-0628-03, are to be dispensed by pharmacists. The medication needs to be stored in a tight, light-resistant container and kept out of reach of kids at USP controlled room temperature. Dosage instructions advise taking one tablet orally daily, with or without food. Patients must see the prescribing information before taking it, and every medication should come with an accompanying medication guide. Unfortunately, no more information is available from the given text.*